NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
31/01/2025
Voltar para busca
Dado oficial do USPTO
MOLECULAR HEALTH MH GUIDE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
41
Atualização mais recente
31/01/2025
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
9, 38, 42, 44
Data de depósito
24/05/2016
Data de registro
18/09/2018
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
31/01/2025
Última transação
31/01/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
702
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
03/06/2016
Primeiro uso no comércio
03/06/2016
Código do desenho
3
Tipo de titular
99
Localização do titular
Heidelberg, DE
Examinador
HISER, CHARLES
Localização atual
Historical data usage
Descrição da marca
The mark consists of the words "MOLECULAR HEALTH" above the larger words "MH GUIDE", the "MH" being in stylized lettering consisting of vertical shapes.
Titulares e representantes
Titulares
Molecular Health GmbH
Representantes
Peter T. Wakiyama Troutman Pepper Hamilton Sanders LLP
Classificação técnica
Classes Nice
Classe 9Classe 38Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 9
Downloadable computer databases containing information in the fields of medicinehealth caregenomicsbioinformaticspharmaceuticalslife sciences and biotechnology; downloadable computer databases containing medical and health information on humans; downloadable computer software for accessingorganizingindexingrankingintegratinglinkingreferencingsynthesizinginterpreting and analyzing information from databases in the fields of medicinehealth caregenomicspharmaceuticalslife sciences and biotechnology and databases containing medical and health information or records about or relating to humans; downloadable mobile applications for mobile devicesfor accessingorganizingsynthesizingindexingrankingintegratinglinkingreferencinginterpreting and analyzing information from databases in the fields of medicinehealth caregenomicsbioinformaticspharmaceuticalslife sciences and biotechnology and databases containing medical and health information or records about or relating to humans; downloadable mobile applications for accessing databases in the fields of medicinehealth caregenomicsbioinformaticspharmaceuticals and pharmaceutical safetylife sciences and biotechnology
Classe 38
Providing access to searchable databases containing medicalpharmaceuticalbiologicalclinical and genomic information and medical and health information and recordsmolecular test results and patient specific data about or relating to humans for scientific research purposes; providing access to online databases containing medicalpharmaceuticalbiologicalclinicalmolecularsequencing and genomic informationdisease informationbiomarker information and medical or health information or records about or relating to humans and patient specific datamolecular test resultsscientific research for medical diagnostic and treatment purposes; providing access to online software and algorithms for retrievalintegrationcorrelationanalysis and interpretation of genomicsequencing and molecular datadiseasesbiomarkersdrug protocolsdrug interactionsclinical profilesmedical and health informationrecords or datapatient specific datamolecular test resultsdata from clinical studiesscientific research for medical diagnostic and treatment purposes; providing access to non-downloadable computer software and algorithms for medical diagnostic and treatment purposes
Classe 42
Consulting and research services in the fields of health caremedicinelife sciencesbiotechnologypharmaceuticalsbioinformaticslife sciencesgenomics and pharmaceuticals and pharmaceutical safety for scientific research purposes; consulting and research services in the nature of retrievalintegrationcorrelationanalysis and interpretation of genomicsequencingmolecular data and information on diseasesbiomarkersdrug protocolsdrug interactionsclinical profilesmedical health information patient specific datamolecular test resultsdata from clinical studiesscientific research for purposes of scientificmedical and pharmaceutical research; designing and developing searchable databases containing medicalpharmaceuticalbiologicalclinical and genomic information and medical and health information and recordsmolecular test results and patient specific data about or relating to humans for scientific research purposes; providing temporary use to non-downloadable computer software and algorithms for retrievalintegrationcorrelationanalysis and interpretation of genomicsequencing and molecular data and information on diseasesbiomarkersdrug protocolsdrug interactionsclinical profilesmedical and health informationpatient specific datamolecular test resultsdata from clinical studiesscientific research for use by physiciansclinicians and other healthcare professionalslaboratory personnelconsultantsscientists and other researchers for purposes of scientificmedical and pharmaceutical research; providing temporary use to non-downloadable computer software and algorithms for retrievalintegrationcorrelationanalysis and interpretation of genomicsequencing and molecular data and information on diseasesbiomarkersdrug protocolsdrug interactionsclinical profilesmedical and health informationpatient specific datamolecular test resultsdata from clinical studiesscientific research for purposes of scientificmedical and pharmaceutical research; providing temporary use to non-downloadable applications for mobile devicessmart phones and tabletsweb applications accessible through the internet providing information in the fields of medicinehealth caregenomicsbioinformaticspharmaceuticalslife sciences and biotechnology for scientific research purposes; data collection services for scientific research purposes in the fields of genomicshealth carepharmaceuticalslife sciencesbioinformaticsbiotechnology and medicine; services for mobile devicessmart phones and tabletsbeing software design; non-downloadable web applications for accessing databases accessible through the internet in the fields of medicinehealth caregenomicsbioinformaticspharmaceuticals and pharmaceutical safetylife sciences and biotechnology; providing temporary use of non-downloadable computer software and algorithms for retrievalintegrationcorrelationanalysis and interpretation of genomicsequencing and molecular data and information on diseasesbiomarkersdrug protocolsdrug interactionsclinical profilesmedical and health informationpatient specific datamolecular test resultsdata from clinical studiesscientific research for medical diagnostic and treatment purposes; medical research servicesthe retrievalintegrationcorrelationanalysis and interpretation of genomicsequencing and molecular datadiseasesbiomarkersdrug protocolsdrug interactionsclinical profilesmedical and health informationrecords or datapatient specific datamolecular test resultsdata from clinical studiesscientific research for medical diagnostic and treatment purposes
Classe 44
Medical consulting servicesthe retrievalintegrationcorrelationanalysis and interpretation of genomicsequencing and molecular datadiseasesbiomarkersdrug protocolsdrug interactionsclinical profilesmedical and health informationrecords or datapatient specific datamolecular test resultsdata from clinical studiesscientific research for medical diagnostic and treatment purposes; consulting services in the fields of medical carepharmaceuticals and medicine; providing medical information in the fields of healthhealthcarelife sciencesbiotechnologypharmaceuticals and pharmaceutical safetybioinformaticsgenetic testing for medical purposes; medical consulting services with respect to the treatment and diagnosis of individuals; providing medical information on drug safety and drug compatibility in relation to therapy and the treatment of individuals; medical consulting services in the fields of diagnostics and patient treatment and treatment protocols
Publicações
Histórico de despachos e eventos da marca no USPTO.
41 publicações encontradas
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
31/01/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
31/01/2025
E815
TEAS SECTION 8 & 15 RECEIVED
13/09/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
18/09/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
18/09/2018
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
17/08/2018
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
16/08/2018
SUPC
STATEMENT OF USE PROCESSING COMPLETE
24/07/2018
IUAF
USE AMENDMENT FILED
11/07/2018
EISU
TEAS STATEMENT OF USE RECEIVED
11/07/2018
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/07/2018
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
21/02/2018
EX1G
SOU EXTENSION 1 GRANTED
20/02/2018
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
20/02/2018
NREV
NOTICE OF REVIVAL - E-MAILED
05/02/2018
TPEX
SOU EXTENSION RECEIVED WITH TEAS PETITION
05/02/2018
PETG
PETITION TO REVIVE-GRANTED
05/02/2018
PROA
TEAS PETITION TO REVIVE RECEIVED
05/02/2018
EXT1
SOU EXTENSION 1 FILED
11/01/2018
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
11/07/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
16/05/2017
PUBO
PUBLISHED FOR OPPOSITION
16/05/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
26/04/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/04/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/04/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/04/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/04/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
27/03/2017
GNRT
NON-FINAL ACTION E-MAILED
27/03/2017
CNRT
NON-FINAL ACTION WRITTEN
27/03/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
16/03/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
15/03/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
15/03/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
15/09/2016
GNRT
NON-FINAL ACTION E-MAILED
15/09/2016
CNRT
NON-FINAL ACTION WRITTEN
15/09/2016
DOCK
ASSIGNED TO EXAMINER
08/09/2016
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
02/06/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/06/2016
NWAP
NEW APPLICATION ENTERED
27/05/2016
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace MOLECULAR HEALTH MH GUIDE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.